secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2023-05-12T23:59:59+00:00
Accession:  0001628280-23-017843
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Better Choice Q1 2023 net sales $9.2M, gross margin up to 35.1% from 27.7%
--------------------------------------------------------------------------

- Net sales $9.2M vs $17.0M in Q1 2022, down 46% YoY; gross sales $12.4M.
- Gross margin 35.1% vs 27.7% YoY; loss from operations improved to $3.3M from $4.0M.
- Adjusted EBITDA loss $1.9M vs $2.0M; net loss $3.5M ($0.11 per share) vs $4.0M ($0.14).
- E-commerce net sales $3.9M, International $2.3M, Brick & Mortar $1.7M, DTC $1.3M.
- New CEO Kent Cunningham appointed; company expects improved balance sheet and operating efficiencies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000162828023017843/0001628280-23-017843-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000162828023017843/bttr-20230512.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-017843

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer